Evernorth Health Services is a major U.S. health services provider and a wholly owned subsidiary of The Cigna Group (NYSE: CI). It specializes in delivering integrated solutions across pharmacy benefits, specialty pharmacy, medical care, and benefits management to enhance access, affordability, and patient outcomes.
Key activities include pharmacy benefit management (PBM) via Express Scripts, one of America's largest PBMs with extensive retail pharmacy networks; specialty pharmacy services through Accredo, supporting complex chronic conditions with dedicated therapeutic resource centers and field nursing; virtual care via MDLIVE; and utilization management with eviCore. Additional offerings encompass behavioral health, provider services, and innovative programs like AI-driven specialty care.
Primarily located in St. Louis, Missouri, the company operates nationwide throughout the United States, serving health plans, employers, government programs, and health systems. It was established in 2020 by rebranding and consolidating Cigna's health services assets, later formalized as the Evernorth Health Services business unit.
In the competitive U.S. healthcare industry, Evernorth positions itself as a leader in connected pharmacy, care, and benefits solutions, leveraging scale and technology to address challenges in specialty medications and complex care while supporting millions of patients and clients.
Also known as Evernorth Health.
None yet. When a new project in the record names Evernorth as owner, partner or investor, it shows here.
The oral OX2R agonist is a Schedule IV controlled substance and will be dispensed through Accredo Specialty Pharmacy.
